TMV-083 Completed Phase 1 Trials for Coronavirus Disease 2019 (COVID‑19) Prevention

IndicationsStatusPurposePhase
CompletedPrevention1
clinicaltrials.gov IdentifierTitleDrugs
NCT04497298Clinical Trial to Evaluate the Safety and Immunogenicity of the COVID-19 Vaccine